3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Terminated
1
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4
Neoplasms
4
Colonic Neoplasms
4
Leukemia, Myeloid, Acute
3
Hodgkin Disease
3
Gallbladder Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Sarcoma
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
HIV Infections
2
Congenital Abnormalities
2
Carcinoma, Renal Cell
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Breast Neoplasms, Male
2
Bile Duct Neoplasms
2
Anus Neoplasms
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Dysplasia
1
Interventions
Gemcitabine
79
Cisplatin
56
pembrolizumab
32
Paclitaxel
28
Carboplatin
24
Docetaxel
19
Radiotherapy
17
Mitomycin
16
Doxorubicin
15
atezolizumab
14
BCG Vaccine
14
Nivolumab
13
Cystectomy
13
Filgrastim
11
vinflunine
10
Methotrexate
10
Vinblastine
9
Fluorouracil
9
5-aminolevulinic acid hexyl ester
9
Sunitinib
7
Early Intervention, Educational
7
durvalumab
6
avelumab
6
Taxes
6
Methods
6
Cystoscopy
6
Albumin-Bound Paclitaxel
6
enfortumab vedotin
5
Trastuzumab
5
Surveys and Questionnaires
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Urinary Bladder Neoplasms
×
Watchful Waiting
×
Clear all
NCT02676180
2023-12-08
DETECT I
University College, London
Completed
3,700 enrolled